Wedbush Morgan Reiterates a 'Strong Buy' on Clean Harbors (CLHB)
CLHB Hot Sheet
Rating Summary:0 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 22 | Down: 8 | New: 36
Wedbush Morgan reiterates a 'Strong Buy' on Clean Harbors (Nasdaq: CLHB). Price target lowered from $87 to $80.
Wedbush analyst says, "Modeling Q3 revenue/EPS of $274.3 million/$0.64 versus consensus of $272.9 million/$0.73. Expecting emergency response projects to easily compensate any shortfall from disruptive hurricane activities...Anticipating positive tone balanced by a prudent outlook in challenging macro environment. Strategic acquisitions expected to support strong base business...No change to our 2008/2009 revenue and EPS estimates of $1.050 billion/$1.133 billion and $2.52/$3.20."
Clean Harbors, Inc., through its subsidiaries, is a provider of environmental services and an operator of non-nuclear hazardous waste treatment facilities in North America.
Wedbush analyst says, "Modeling Q3 revenue/EPS of $274.3 million/$0.64 versus consensus of $272.9 million/$0.73. Expecting emergency response projects to easily compensate any shortfall from disruptive hurricane activities...Anticipating positive tone balanced by a prudent outlook in challenging macro environment. Strategic acquisitions expected to support strong base business...No change to our 2008/2009 revenue and EPS estimates of $1.050 billion/$1.133 billion and $2.52/$3.20."
Clean Harbors, Inc., through its subsidiaries, is a provider of environmental services and an operator of non-nuclear hazardous waste treatment facilities in North America.
You May Also Be Interested In
- Nomura Securities Maintains a 'Buy' on Melco Crown Entertainment (MPEL); Raising PT and Estimates
- UBS Maintains a 'Neutral' on Ralcorp Holdings (RAH); Trimming Numbers After Q2 Miss
- Goldman Sachs Boosts Target on Williams-Sonoma (WSM) On Signs of Stabilization
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
Wedbush MorganSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
